Search
Icecure Medical Ltd
ICCMAdd to Watchlist
5.450USD
+0.170+3.22%
Market hours （ET）Quotes delayed by 15 min
442.43MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Icecure Medical Ltd is 8.00, ranking 69 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 3.12, with a high of 3.25 and a low of 3.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
44.500
Target Price
+815.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
3
Median
6
Average
Company name
Ratings
Analysts
Icecure Medical Ltd
ICCM
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Icecure Medical Ltd's expected revenue for the next quarter?
Icecure Medical Ltd's expected revenue is 1.45M.
What is Icecure Medical Ltd's price target?
Analysts forecast that Icecure Medical Ltd's price target is USD 3.12, with the highest forecast at USD 3.25 and the lowest forecast at USD 3.00.
How have Icecure Medical LtdICCM's recent earnings per share performed?
The market expectation was USD -0.06, while Icecure Medical LtdICCM's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -1.50.
What is the analyst rating for Icecure Medical Ltd?
Based on the ratings of Icecure Medical Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.